Drug Profile
Follitropin alfa biosimilar - GEMA
Alternative Names: Folitime; r-hFSH biosimilar - GEMA; recombinant humanfollicle stimulating hormone - GEMALatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator GEMA
- Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins; Recombinant proteins
- Mechanism of Action Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Female infertility
Most Recent Events
- 04 Dec 2018 No recent reports on development identified - Phase-III for Female infertility in Argentina (SC)
- 01 Dec 2016 GEMA completes a phase III trial in Female infertility in Argentina (SC) (NCT02454556)
- 01 Apr 2015 Phase-III clinical trials in Female infertility in Argentina (SC)